NM_021186.5:c.214G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_021186.5(ZP4):c.214G>A(p.Asp72Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021186.5 missense
Scores
Clinical Significance
Conservation
Publications
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZP4 | ENST00000366570.5 | c.214G>A | p.Asp72Asn | missense_variant | Exon 2 of 12 | 1 | NM_021186.5 | ENSP00000355529.4 | ||
| ENSG00000237250 | ENST00000450451.1 | n.410+7570C>T | intron_variant | Intron 4 of 11 | 1 | |||||
| ZP4 | ENST00000611898.4 | c.214G>A | p.Asp72Asn | missense_variant | Exon 2 of 13 | 5 | ENSP00000482304.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152062Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251362 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461846Hom.: 0 Cov.: 39 AF XY: 0.0000261 AC XY: 19AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152062Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74286 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.214G>A (p.D72N) alteration is located in exon 2 (coding exon 2) of the ZP4 gene. This alteration results from a G to A substitution at nucleotide position 214, causing the aspartic acid (D) at amino acid position 72 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Prostate cancer Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at